Questions stringlengths 22 157 ⌀ | Answers stringlengths 95 1.52k ⌀ | text stringlengths 32 1.68k |
|---|---|---|
How is breast cancer treated? | Surgery is considered primary treatment for early-stage breast cancer; many patients are cured with surgery alone.Adjuvant treatment of breast cancer is designed to treat micrometastatic disease (ie, breast cancer cells that have escaped the breast and regional lymph nodes but which have not yet had an established iden... | <s>[INST] How is breast cancer treated? [/INST] Surgery is considered primary treatment for early-stage breast cancer; many patients are cured with surgery alone.Adjuvant treatment of breast cancer is designed to treat micrometastatic disease (ie, breast cancer cells that have escaped the breast and regional lymph node... |
How is invasive breast cancer treated? | There are many treatments for invasive breast cancer. They include:
1) Surgery. A lumpectomy is a surgical procedure in which a surgeon removes the cancer and a small area of healthy tissue around it. A mastectomy may be performed after chemotherapy. This procedure removes all of your breast.
2) Chemotherapy. This dr... | <s>[INST] How is invasive breast cancer treated? [/INST] There are many treatments for invasive breast cancer. They include:
1) Surgery. A lumpectomy is a surgical procedure in which a surgeon removes the cancer and a small area of healthy tissue around it. A mastectomy may be performed after chemotherapy. This proced... |
What are the guidelines for breast-conserving surgery with whole-breast irradiation (WBI) in stages I and II invasive breast cancer? | The following are guidelines, released by the Society of Surgical Oncology and the American Society for Radiation Oncology:
1) Positive margins are associated with at least a 2-fold increase in ipsilateral breast tumor recurrence (IBTR)
2) Negative margins optimize IBTR; this risk is not significantly lowered by wide... | <s>[INST] What are the guidelines for breast-conserving surgery with whole-breast irradiation (WBI) in stages I and II invasive breast cancer? [/INST] The following are guidelines, released by the Society of Surgical Oncology and the American Society for Radiation Oncology:
1) Positive margins are associated with at l... |
What is the role of post lumpectomy radiation therapy in the treatment of breast cancer? | > The purpose of radiation therapy after breast-conserving surgery is to eradicate local subclinical residual disease while reducing local recurrence rates by approximately 75%. On the basis of results from several randomized controlled studies, irradiation of the intact breast is considered standard of care, even in t... | <s>[INST] What is the role of post lumpectomy radiation therapy in the treatment of breast cancer? [/INST] > The purpose of radiation therapy after breast-conserving surgery is to eradicate local subclinical residual disease while reducing local recurrence rates by approximately 75%. On the basis of results from severa... |
What are the ASBrS selection criteria for treatment of breast cancer with accelerated partial breast irradiation (PBI)? | The American Society of Breast Surgeons (ASBrS) recommends the following selection criteria when patients are being considered for treatment with accelerated PBI :
1) Age ≥45 years for all tumor types
2) All invasive subtypes or DCIS
3) Total tumor size (invasive and DCIS) ≤ 3 cm
4) T stage Tis, T1, T2 (≤ 3 cm)
5) Ma... | <s>[INST] What are the ASBrS selection criteria for treatment of breast cancer with accelerated partial breast irradiation (PBI)? [/INST] The American Society of Breast Surgeons (ASBrS) recommends the following selection criteria when patients are being considered for treatment with accelerated PBI :
1) Age ≥45 years ... |
What are the potential complications of partial breast irradiation (PBI) in the treatment of breast cancer? | Potential complications of PBI are catheter placement followed by removal secondary to any of the following:
1) Inadequate skin spacing
2) Infection
3) Seroma
4) Fibrosis
5) Chronic pain
6) Disease recurrence | <s>[INST] What are the potential complications of partial breast irradiation (PBI) in the treatment of breast cancer? [/INST] Potential complications of PBI are catheter placement followed by removal secondary to any of the following:
1) Inadequate skin spacing
2) Infection
3) Seroma
4) Fibrosis
5) Chronic pain
6) Dis... |
What is the efficacy of external-beam radiotherapy (EBRT) in the treatment of breast cancer? | The most common type of radiation therapy for breast cancer, EBRT is generally given after other treatments are complete.
In EBRT, a beam of radiation, a high-energy X-ray, is focused on the spot where the cancer was removed. If a lumpectomy was performed, a patient may receive EBRT to the entire breast, a technique c... | <s>[INST] What is the efficacy of external-beam radiotherapy (EBRT) in the treatment of breast cancer? [/INST] The most common type of radiation therapy for breast cancer, EBRT is generally given after other treatments are complete.
In EBRT, a beam of radiation, a high-energy X-ray, is focused on the spot where the ca... |
What is the role of single-dose radiotherapy in the treatment of breast cancer? | According to 2 major studies, single-dose radiotherapy delivered during or soon after surgery for breast cancer is a viable alternative to conventional EBRT in selected patients who are at low risk for local recurrence. | <s>[INST] What is the role of single-dose radiotherapy in the treatment of breast cancer? [/INST] According to 2 major studies, single-dose radiotherapy delivered during or soon after surgery for breast cancer is a viable alternative to conventional EBRT in selected patients who are at low risk for local recurrence. </... |
What are the ASCO criteria for postmastectomy radiation therapy in the treatment of breast cancer? | Clinical practice guidelines developed by the American Society of Clinical Oncology (ASCO), along with several prospective, randomized clinical trials, recommend that postmastectomy radiation therapy be performed according to the following criteria :
1) Positive postmastectomy margins
2) Primary tumors >5 cm
3) Involv... | <s>[INST] What are the ASCO criteria for postmastectomy radiation therapy in the treatment of breast cancer? [/INST] Clinical practice guidelines developed by the American Society of Clinical Oncology (ASCO), along with several prospective, randomized clinical trials, recommend that postmastectomy radiation therapy be ... |
What is the efficacy of radiation therapy for the treatment of invasive breast cancer? | If early-stage breast cancer hasn’t spread, radiation therapy after a lumpectomy significantly reduces the risk of cancer coming back by approximately 50%. Studies show that a lumpectomy followed by radiation therapy is as effective as a mastectomy without radiation therapy. | <s>[INST] What is the efficacy of radiation therapy for the treatment of invasive breast cancer? [/INST] If early-stage breast cancer hasn’t spread, radiation therapy after a lumpectomy significantly reduces the risk of cancer coming back by approximately 50%. Studies show that a lumpectomy followed by radiation therap... |
What is the role of systemic adjuvant therapy in the treatment of breast cancer? | Adjuvant treatment of breast cancer is designed to treat micrometastatic disease (ie, breast cancer cells that have escaped the breast and regional lymph nodes but which have not yet had an established identifiable metastasis). Treatment is aimed at reducing the risk of future recurrence, thereby reducing breast cancer... | <s>[INST] What is the role of systemic adjuvant therapy in the treatment of breast cancer? [/INST] Adjuvant treatment of breast cancer is designed to treat micrometastatic disease (ie, breast cancer cells that have escaped the breast and regional lymph nodes but which have not yet had an established identifiable metast... |
How is DCIS breast cancer treated? | Currently, the standard treatment of DCIS is surgical resection with or without radiation. Adjuvant radiation and hormonal therapies are often reserved for younger women, patients undergoing lumpectomy, or those with the comedo subtype. Local treatment for DCIS usually involves breast-conserving therapy (BCT), which co... | <s>[INST] How is DCIS breast cancer treated? [/INST] Currently, the standard treatment of DCIS is surgical resection with or without radiation. Adjuvant radiation and hormonal therapies are often reserved for younger women, patients undergoing lumpectomy, or those with the comedo subtype. Local treatment for DCIS usual... |
What is the role of WBRT in the treatment of DCIS breast cancer? | In DCIS, WBRT is delivered over 5-6 weeks after surgery, reducing the local recurrence rate by approximately 60%. Roughly 50% of local recurrences are invasive breast cancer. Meta-analyses of randomized controlled trials have demonstrated slightly higher rates of contralateral breast cancer with radiation therapy than ... | <s>[INST] What is the role of WBRT in the treatment of DCIS breast cancer? [/INST] In DCIS, WBRT is delivered over 5-6 weeks after surgery, reducing the local recurrence rate by approximately 60%. Roughly 50% of local recurrences are invasive breast cancer. Meta-analyses of randomized controlled trials have demonstrate... |
What is the role of tamoxifen in the treatment of DCIS breast cancer? | Tamoxifen is the only hormonal therapy currently approved for adjuvant therapy in patients treated with breast-conserving surgery and radiation for DCIS. A retrospective study found that patients with ER-positive DCIS who were treated with tamoxifen showed significant decreases in subsequent breast cancer at 10 years. ... | <s>[INST] What is the role of tamoxifen in the treatment of DCIS breast cancer? [/INST] Tamoxifen is the only hormonal therapy currently approved for adjuvant therapy in patients treated with breast-conserving surgery and radiation for DCIS. A retrospective study found that patients with ER-positive DCIS who were treat... |
How is LCIS breast cancer treated? | Overall, treatment options for lobular carcinoma in situ (LCIS) include observation and close follow-up care with or without tamoxifen and bilateral mastectomy with or without reconstruction. There is no evidence of therapeutic benefit from local excision, axillary dissection, radiotherapy, or chemotherapy. LCIS in the... | <s>[INST] How is LCIS breast cancer treated? [/INST] Overall, treatment options for lobular carcinoma in situ (LCIS) include observation and close follow-up care with or without tamoxifen and bilateral mastectomy with or without reconstruction. There is no evidence of therapeutic benefit from local excision, axillary d... |
How is locally advanced breast cancer (LABC) and inflammatory breast cancer (IBC) treated? | LABC is often treated with a combination of chemotherapy, surgery, and radiation therapy.
NOTE: Chemotherapy is not given every day but instead is given in cycles. A cycle of chemotherapy refers to the time it takes to give the chemotherapy and then allow the body to recover. A cycle of chemotherapy typically ranges ... | <s>[INST] How is locally advanced breast cancer (LABC) and inflammatory breast cancer (IBC) treated? [/INST] LABC is often treated with a combination of chemotherapy, surgery, and radiation therapy.
NOTE: Chemotherapy is not given every day but instead is given in cycles. A cycle of chemotherapy refers to the time it... |
What is the prognosis of locally advanced breast cancer (LABC) and inflammatory breast cancer (IBC) following treatment? | Overall, the prognosis is better for women with T3N0 (stage IIB) and T3N1 (stage IIIA) breast cancer than it is for those with classically defined LABC (IIIB, IIIC) or IBC (IIIB, T4d). Disease-free survival (DFS) and overall survival are typically better for stage IIB and IIIA patients; however, the likelihood of achie... | <s>[INST] What is the prognosis of locally advanced breast cancer (LABC) and inflammatory breast cancer (IBC) following treatment? [/INST] Overall, the prognosis is better for women with T3N0 (stage IIB) and T3N1 (stage IIIA) breast cancer than it is for those with classically defined LABC (IIIB, IIIC) or IBC (IIIB, T4... |
What is inflammatory breast cancer (IBC)? | IBC is a clinical diagnosis that implies presentation with the cardinal signs of inflammation (calor [warmth], rubor [redness], tumor [mass]) involving the breast, although the warmth may be subtle and the mass may not be appreciated as something discrete. Indeed, even when a localized mass is apparent in IBC, the true... | <s>[INST] What is inflammatory breast cancer (IBC)? [/INST] IBC is a clinical diagnosis that implies presentation with the cardinal signs of inflammation (calor [warmth], rubor [redness], tumor [mass]) involving the breast, although the warmth may be subtle and the mass may not be appreciated as something discrete. Ind... |
What is locally advanced breast cancer (LABC)? | LABC is more common in the US than IBC is; by the definition used here, it may account for 10-15% of patients (this drops to about 5% if one uses the older, stricter definition that includes inoperability). Epidemiologically, LABC is associated with lower socioeconomic class and, probably for that reason, with black ra... | <s>[INST] What is locally advanced breast cancer (LABC)? [/INST] LABC is more common in the US than IBC is; by the definition used here, it may account for 10-15% of patients (this drops to about 5% if one uses the older, stricter definition that includes inoperability). Epidemiologically, LABC is associated with lower... |
How are lymph nodes evaluated in locally advanced breast cancer (LABC) and inflammatory breast cancer (IBC)? | Patients with LABC or IBC with clinically positive nodes should undergo a core biopsy before initiating chemotherapy. Those with clinically negative nodes may undergo sentinel lymph node biopsy before they start treatment, or else sentinel node determination may be delayed until after treatment is completed. In general... | <s>[INST] How are lymph nodes evaluated in locally advanced breast cancer (LABC) and inflammatory breast cancer (IBC)? [/INST] Patients with LABC or IBC with clinically positive nodes should undergo a core biopsy before initiating chemotherapy. Those with clinically negative nodes may undergo sentinel lymph node biopsy... |
What are the systemic treatments for metastatic breast cancer? | Although treatments for metastatic breast cancer continue to improve, there remains no cure once distant metastases develop.
Furthermore, although occasional patients with metastatic breast cancer benefit from surgical resection for an isolated recurrence and many require radiation therapy for palliation at a specific ... | <s>[INST] What are the systemic treatments for metastatic breast cancer? [/INST] Although treatments for metastatic breast cancer continue to improve, there remains no cure once distant metastases develop.
Furthermore, although occasional patients with metastatic breast cancer benefit from surgical resection for an iso... |
What is the role of hormone therapy in the treatment of metastatic breast cancer? | Hormone therapy (also called hormonal therapy, hormone treatment, or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering with effects of hormones on breast cancer cells. Tumors that are hormone insensitive do not have hormone rece... | <s>[INST] What is the role of hormone therapy in the treatment of metastatic breast cancer? [/INST] Hormone therapy (also called hormonal therapy, hormone treatment, or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering with effe... |
What is the role of chemotherapy in the treatment of metastatic breast cancer? | Chemotherapy is used as a treatment for most people who have metastatic breast cancer. Whether it is used first-line or not depends on your receptor status, previous treatments, and other factors Chemotherapy can work very well for metastatic breast cancer, although tumors almost always become resistant to any given dr... | <s>[INST] What is the role of chemotherapy in the treatment of metastatic breast cancer? [/INST] Chemotherapy is used as a treatment for most people who have metastatic breast cancer. Whether it is used first-line or not depends on your receptor status, previous treatments, and other factors Chemotherapy can work very ... |
Which chemotherapy agents are used in the treatment of metastatic breast cancer? | Check out the agents: https://www.medscape.com/answers/1947145-155366/what-is-the-role-of-chemotherapy-in-the-treatment-of-metastatic-breast-cancer | <s>[INST] Which chemotherapy agents are used in the treatment of metastatic breast cancer? [/INST] Check out the agents: https://www.medscape.com/answers/1947145-155366/what-is-the-role-of-chemotherapy-in-the-treatment-of-metastatic-breast-cancer </s> |
What is the role of poly (ADP-ribose) polymerase (PARP) inhibitors in the treatment of metastatic breast cancer? | PARP inhibitors are a type of targeted (biological) therapy.
PARP stands for poly-ADP ribose polymerase. It’s a protein that helps cells repair themselves if they become damaged. PARP inhibitors stop the PARP from repairing cancer cells.
Two inherited altered genes that increase the risk of breast cancer developing a... | <s>[INST] What is the role of poly (ADP-ribose) polymerase (PARP) inhibitors in the treatment of metastatic breast cancer? [/INST] PARP inhibitors are a type of targeted (biological) therapy.
PARP stands for poly-ADP ribose polymerase. It’s a protein that helps cells repair themselves if they become damaged. PARP inhi... |
What is the efficacy of combination therapy in the treatment of triple-negative breast cancer? | Unresectable metastatic triple-negative breast cancer (ie, estrogen receptor–negative, progesterone receptor–negative, and HER2 receptor–negative) is aggressive and carries a poor prognosis. However, combination therapy with the programmed cell death ligand–1 (PDL1) inhibitor atezolizumab plus nanoparticle albumin-boun... | <s>[INST] What is the efficacy of combination therapy in the treatment of triple-negative breast cancer? [/INST] Unresectable metastatic triple-negative breast cancer (ie, estrogen receptor–negative, progesterone receptor–negative, and HER2 receptor–negative) is aggressive and carries a poor prognosis. However, combina... |
What is the role of antiangiogenic therapy in the treatment of metastatic breast cancer? | null | <s>[INST] What is the role of antiangiogenic therapy in the treatment of metastatic breast cancer? [/INST] None </s> |
What is the role of surgery for the treatment of metastatic breast cancer? | There is increasing interest in the role of surgical intervention for the intact primary tumor of these metastatic breast cancer patients. Several single-institution cohort and retrospective studies have concluded that surgical resection of the intact primary tumor may provide a survival advantage.
It is still unknown... | <s>[INST] What is the role of surgery for the treatment of metastatic breast cancer? [/INST] There is increasing interest in the role of surgical intervention for the intact primary tumor of these metastatic breast cancer patients. Several single-institution cohort and retrospective studies have concluded that surgical... |
What is the role of tamoxifen and raloxifene for the reduction of breast cancer risk? |
Two selective estrogen receptor modulators (SERMs), tamoxifen and raloxifene, are approved for reduction of breast cancer risk in high-risk women. Two NSABP trials (P1 and P2) showed that tamoxifen reduced the risk of DCIS and invasive breast cancer by 30-50%. In the NSABP P2 prevention trial, raloxifene was as effect... | <s>[INST] What is the role of tamoxifen and raloxifene for the reduction of breast cancer risk? [/INST]
Two selective estrogen receptor modulators (SERMs), tamoxifen and raloxifene, are approved for reduction of breast cancer risk in high-risk women. Two NSABP trials (P1 and P2) showed that tamoxifen reduced the risk ... |
What are the ASCO guidelines for the pharmacologic reduction of breast cancer risk? | ASCO guidelines on endocrine therapy to reduce breast cancer risk recommend the following :
1) In premenopausal women who are at least 35 years old and have completed childbearing, tamoxifen (20 mg/day for 5 years) remains the standard of care for risk reduction. Low-dose tamoxifen (5 mg/day) may be an alternative in ... | <s>[INST] What are the ASCO guidelines for the pharmacologic reduction of breast cancer risk? [/INST] ASCO guidelines on endocrine therapy to reduce breast cancer risk recommend the following :
1) In premenopausal women who are at least 35 years old and have completed childbearing, tamoxifen (20 mg/day for 5 years) re... |
What is the role of mastectomy in the prevention of breast cancer? | In retrospective studies with median follow-up periods of 13-14 years, bilateral risk-reduction mastectomy decreased the risk of developing breast cancer by at least 90% in women at moderate to high risk and in those with known BRCA1/2 mutations. In women with deleterious mutations in other genes that are associated wi... | <s>[INST] What is the role of mastectomy in the prevention of breast cancer? [/INST] In retrospective studies with median follow-up periods of 13-14 years, bilateral risk-reduction mastectomy decreased the risk of developing breast cancer by at least 90% in women at moderate to high risk and in those with known BRCA1/2... |
What are the ASBrS recommendations for contralateral prophylactic mastectomy (CPM) in the treatment of breast cancer? | A consensus statement from the American Society of Breast Surgeons (ASBrS) recommends that women with unilateral breast cancer who are at average risk should be discouraged from undergoing a contralateral prophylactic mastectomy (CPM), because most of those women, with the possible exception of BRCA carriers, will not ... | <s>[INST] What are the ASBrS recommendations for contralateral prophylactic mastectomy (CPM) in the treatment of breast cancer? [/INST] A consensus statement from the American Society of Breast Surgeons (ASBrS) recommends that women with unilateral breast cancer who are at average risk should be discouraged from underg... |
What are the differences between the NCCN and ASCO guidelines for the long-term monitoring of breast cancer survivors? | Check out the table to know the difference between NCCN and ASCO guidelines : https://emedicine.medscape.com/article/1947145-treatment#d16 | <s>[INST] What are the differences between the NCCN and ASCO guidelines for the long-term monitoring of breast cancer survivors? [/INST] Check out the table to know the difference between NCCN and ASCO guidelines : https://emedicine.medscape.com/article/1947145-treatment#d16 </s> |
What are ASCO guidelines for monitoring bone density following the treatment for breast cancer? | Women aged ≥65 years
-----------------------------------------------------------------------
Woman aged 60-64 years with ≥1 of the following:
1. Family history of osteoporosis
2. Low body weight
3. Prior nontraumatic fracture
4. Other risk factors (eg, smoking, sedentary lifestyle)
--------------------------------... | <s>[INST] What are ASCO guidelines for monitoring bone density following the treatment for breast cancer? [/INST] Women aged ≥65 years
-----------------------------------------------------------------------
Woman aged 60-64 years with ≥1 of the following:
1. Family history of osteoporosis
2. Low body weight
3. Prior... |
What is the role of postoperative imaging in the long-term monitoring of breast cancer? | Women who have had surgery for breast cancer may still require breast cancer screening with mammography. If a woman had a total mastectomy, then the other breast requires yearly follow-up, because there is still a higher risk that cancer will develop in the remaining breast. If the woman had a subcutaneous mastectomy, ... | <s>[INST] What is the role of postoperative imaging in the long-term monitoring of breast cancer? [/INST] Women who have had surgery for breast cancer may still require breast cancer screening with mammography. If a woman had a total mastectomy, then the other breast requires yearly follow-up, because there is still a ... |
What is the role of postoperative imaging in the monitoring of metastatic breast cancer? | Recommendations for monitoring disease response in the metastatic setting vary. In general, monthly evaluations consisting of a history and physical examination to evaluate progression of disease and toxicities are reasonable.
Measurement of tumor markers, such as CEA, CA15.3, and CA27.29, can be used in conjunction w... | <s>[INST] What is the role of postoperative imaging in the monitoring of metastatic breast cancer? [/INST] Recommendations for monitoring disease response in the metastatic setting vary. In general, monthly evaluations consisting of a history and physical examination to evaluate progression of disease and toxicities ar... |
How is radiation-induced heart disease monitored in patients with breast cancer? | According to a consensus statement from the European Association of Cardiovascular Imaging and the American Society of Echocardiography, patients treated with radiotherapy to the chest for Hodgkin's disease, or breast, lung, or esophageal cancer, should have an echocardiogram every 5 to 10 years to detect radiation-ind... | <s>[INST] How is radiation-induced heart disease monitored in patients with breast cancer? [/INST] According to a consensus statement from the European Association of Cardiovascular Imaging and the American Society of Echocardiography, patients treated with radiotherapy to the chest for Hodgkin's disease, or breast, lu... |
What are Society for Integrative Oncology guidelines for use of integrative therapy in breast cancer? | The Society for Integrative Oncology has released clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. Recommendations include the following :
1) Meditation, yoga, and relaxation with imagery may be useful for alleviating anxiety and mood disorders... | <s>[INST] What are Society for Integrative Oncology guidelines for use of integrative therapy in breast cancer? [/INST] The Society for Integrative Oncology has released clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. Recommendations include the... |
Which organizations have issued guidelines on breast cancer screening? | Guidelines on breast cancer screening have been issued by the following organizations:
1) American Cancer Society (ACS)
2) U.S. Preventive Services Task Force (USPSTF)
3) American College of Obstetricians and Gynecologists (ACOG)
4) European Commission Initiative on Breast Cancer (ECIBC) | <s>[INST] Which organizations have issued guidelines on breast cancer screening? [/INST] Guidelines on breast cancer screening have been issued by the following organizations:
1) American Cancer Society (ACS)
2) U.S. Preventive Services Task Force (USPSTF)
3) American College of Obstetricians and Gynecologists (ACOG)
... |
What are the ACS guidelines for breast self-exam (BSE)? | ACS recommendations for BSE are as follows :
1) Women should begin regular screening mammography at age 45 years (strong recommendation)
2) Women aged 45-54 years should be screened annually (qualified recommendation)
3) Women 55 years and older should transition to biennial screening or have the opportunity to contin... | <s>[INST] What are the ACS guidelines for breast self-exam (BSE)? [/INST] ACS recommendations for BSE are as follows :
1) Women should begin regular screening mammography at age 45 years (strong recommendation)
2) Women aged 45-54 years should be screened annually (qualified recommendation)
3) Women 55 years and older... |
What are ACS guidelines for the use of MRI in breast cancer screening? | The ACS considers a woman to be at average risk for breast cancer in the absence of all of the following:
A personal history of breast cancer
A strong family history of breast cancer
A genetic mutation known to increase risk of breast cancer (eg, in BRCA)
A history of chest radiation therapy before the age of 30
For a... | <s>[INST] What are ACS guidelines for the use of MRI in breast cancer screening? [/INST] The ACS considers a woman to be at average risk for breast cancer in the absence of all of the following:
A personal history of breast cancer
A strong family history of breast cancer
A genetic mutation known to increase risk of br... |
What are the USPSTF guidelines for breast self-exam (BSE)? | In 2016, the USPSTF released updated recommendations on breast cancer screening, but did not update its 2009 recommendations for breast examination. In its 2016 statement, the USPSTF encouraged patients to be aware of changes in their bodies and discussing these changes with clinicians.
The 2009 breast examination rec... | <s>[INST] What are the USPSTF guidelines for breast self-exam (BSE)? [/INST] In 2016, the USPSTF released updated recommendations on breast cancer screening, but did not update its 2009 recommendations for breast examination. In its 2016 statement, the USPSTF encouraged patients to be aware of changes in their bodies a... |
What are the USPSTF guidelines for breast cancer screening? | Since 2009 the USPSTF has recommended biennial screening mammography for women aged 50-74 years (grade B recommendation). The USPSTF recommends against routine screening mammography in women aged 40-49 years because of high rates of false-negative findings, perceived harm of unnecessary biopsy, and concern for the harm... | <s>[INST] What are the USPSTF guidelines for breast cancer screening? [/INST] Since 2009 the USPSTF has recommended biennial screening mammography for women aged 50-74 years (grade B recommendation). The USPSTF recommends against routine screening mammography in women aged 40-49 years because of high rates of false-neg... |
What are the USPSTF guidelines for BRCA-related breast cancer screening? | In 2013, the USPSTF issued updated guidelines on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women. The current USPSTF recommendations are as follows:
Women who have family members with breast, ovarian, tubal, or peritoneal cancer should be screened to identify a family history ... | <s>[INST] What are the USPSTF guidelines for BRCA-related breast cancer screening? [/INST] In 2013, the USPSTF issued updated guidelines on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women. The current USPSTF recommendations are as follows:
Women who have family members with br... |
How are the ACOG guidelines for breast cancer screening categorized? | The ACOG released guidelines for breast cancer risk assessment and screening in average-risk women in 2017. [184] For women at average risk, ACOG categorizes its recommendations as follows:
Level A – Based on good and consistent scientific evidence
Level B – Based on limited or inconsistent scientific evidence
Level C... | <s>[INST] How are the ACOG guidelines for breast cancer screening categorized? [/INST] The ACOG released guidelines for breast cancer risk assessment and screening in average-risk women in 2017. [184] For women at average risk, ACOG categorizes its recommendations as follows:
Level A – Based on good and consistent sci... |
According to ACOG guidelines, which breast cancer risk factors should be periodically assessed in women? | ACOG recommends that health care providers periodically assess patients' breast cancer risk by reviewing the history (level B). Breast cancer risk factors include the following:
Family history of breast cancer, ovarian cancer, or other hereditary breast and ovatrians syndrome-associated cancer (eg, prostate cancer, pa... | <s>[INST] According to ACOG guidelines, which breast cancer risk factors should be periodically assessed in women? [/INST] ACOG recommends that health care providers periodically assess patients' breast cancer risk by reviewing the history (level B). Breast cancer risk factors include the following:
Family history of ... |
What are the ACOG guidelines for clinical breast exam to screen for breast cancer? | Women should be counseled about breast self-awareness (ie, awareness of the normal appearance and feel of their breasts) and encouraged to notify their health care provider if they experience a change (level C). However, breast self-examination is not recommended (level B).
Clinical breast examination remains a recomm... | <s>[INST] What are the ACOG guidelines for clinical breast exam to screen for breast cancer? [/INST] Women should be counseled about breast self-awareness (ie, awareness of the normal appearance and feel of their breasts) and encouraged to notify their health care provider if they experience a change (level C). However... |
What are the ACOG recommendations for breast cancer screening mammography? | The decision about the age to begin mammography screening should be made through a shared decision-making process that includes information about the potential benefits and harms. Recommendations (level A) for average-risk women are as follows:
Screening mammography should be offered starting at age 40 years.
If pati... | <s>[INST] What are the ACOG recommendations for breast cancer screening mammography? [/INST] The decision about the age to begin mammography screening should be made through a shared decision-making process that includes information about the potential benefits and harms. Recommendations (level A) for average-risk wome... |
What are European Commission Initiative on Breast Cancer (ECIBC) screening guidelines? | The European Commission Initiative on Breast Cancer (ECIBC) screening guidelines include the following recommendations for women age 40-74 years who are at average risk of breast cancer [185] :
Age 40-44: no screening
Age 45-49: screening every 2 or 3 years
Age 50-69: screening every 2 years
Age 70-74: screening ever... | <s>[INST] What are European Commission Initiative on Breast Cancer (ECIBC) screening guidelines? [/INST] The European Commission Initiative on Breast Cancer (ECIBC) screening guidelines include the following recommendations for women age 40-74 years who are at average risk of breast cancer [185] :
Age 40-44: no screen... |
Which organizations have issued guidelines for pharmacologic intervention for breast cancer risk reduction? | Guidelines for pharmacologic intervention in women who are at increased risk for breast cancer, but do not have a personal history of breast cancer, have been issued by the American Society of Clinical Oncology (ASCO) and the U.S. Preventive Services Task Force (USPSTF). The guidelines differ in their classification of... | <s>[INST] Which organizations have issued guidelines for pharmacologic intervention for breast cancer risk reduction? [/INST] Guidelines for pharmacologic intervention in women who are at increased risk for breast cancer, but do not have a personal history of breast cancer, have been issued by the American Society of C... |
What are the ASCO guidelines on pharmacologic interventions for breast cancer risk reduction? | ASCO guidelines recommend the following [186] :
For premenopausal or postmenopausal women with increased risk for breast cancer, offer tamoxifen (20 mg/day for 5 years) to reduce the risk of invasive ER-positive breast cancer
In postmenopausal women, raloxifene (60 mg/day for 5 years) may also be considered
Off-labe... | <s>[INST] What are the ASCO guidelines on pharmacologic interventions for breast cancer risk reduction? [/INST] ASCO guidelines recommend the following [186] :
For premenopausal or postmenopausal women with increased risk for breast cancer, offer tamoxifen (20 mg/day for 5 years) to reduce the risk of invasive ER-posi... |
What are the ASCO recommendations for use of tamoxifen in breast cancer risk reduction? | ASCO guidelines recommend that use of tamoxifen, 20 mg per day orally for 5 years, should be discussed as an option to reduce the risk of invasive breast cancer (BC), specifically ER-positive BC, in women 35 years of age or older who are premenopausal or postmenopausal and have a 5-year projected absolute breast cancer... | <s>[INST] What are the ASCO recommendations for use of tamoxifen in breast cancer risk reduction? [/INST] ASCO guidelines recommend that use of tamoxifen, 20 mg per day orally for 5 years, should be discussed as an option to reduce the risk of invasive breast cancer (BC), specifically ER-positive BC, in women 35 years ... |
What are the ASCO recommendations for use of raloxifene in breast cancer risk reduction? | ASCO guidelines recommend that raloxifene should be discussed as an option to reduce the risk of invasive BC, specifically ER-positive BC, in postmenopausal women who are age ≥ 35 years with a 5-year projected absolute BC risk ≥ 1.66% or with LCIS. Raloxifene is given in a dosage of 60 mg/ day orally for 5 years; it ca... | <s>[INST] What are the ASCO recommendations for use of raloxifene in breast cancer risk reduction? [/INST] ASCO guidelines recommend that raloxifene should be discussed as an option to reduce the risk of invasive BC, specifically ER-positive BC, in postmenopausal women who are age ≥ 35 years with a 5-year projected abs... |
What are the ASCO recommendations for use of exemestane in breast cancer risk reduction? | Exemestane is not FDA approved for breast cancer risk reduction. However, ASCO guidelines recommend that it should be discussed as an alternative to tamoxifen and/or raloxifene to reduce the risk of invasive BC, specifically ER-positive BC, in postmenopausal women age ≥ 35 years with a 5-year projected absolute BC risk... | <s>[INST] What are the ASCO recommendations for use of exemestane in breast cancer risk reduction? [/INST] Exemestane is not FDA approved for breast cancer risk reduction. However, ASCO guidelines recommend that it should be discussed as an alternative to tamoxifen and/or raloxifene to reduce the risk of invasive BC, s... |
What are the USPSTF guidelines on pharmacologic interventions for breast cancer risk reduction? | The USPSTF updated its guidelines for primary breast cancer risk reduction in 2019. [178] The USPSTF recommends that clinicians engage in shared, informed decision making with women who are at increased risk for breast cancer about medications to reduce their risk. For women who are at increased risk for breast cancer... | <s>[INST] What are the USPSTF guidelines on pharmacologic interventions for breast cancer risk reduction? [/INST] The USPSTF updated its guidelines for primary breast cancer risk reduction in 2019. [178] The USPSTF recommends that clinicians engage in shared, informed decision making with women who are at increased ri... |
Which organizations have issued guidelines for sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) in the treatment of breast cancer? | Guidelines for sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) have been issued by the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN). | <s>[INST] Which organizations have issued guidelines for sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) in the treatment of breast cancer? [/INST] Guidelines for sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) have been issued by the American Society of Clinical ... |
What are the ASCO guidelines for the use of sentinel lymph node biopsy (SLNB) in the treatment of breast cancer? | A 2016 update on SLNB for patients with operable early-stage breast cancer by ASCO advises that SLNB may be offered to the following patients:
Women with multicentric tumors
Women with DCIS who will be undergoing mastectomy
Women who previously underwent breast and/or axillary surgery
Women who received preoperative/n... | <s>[INST] What are the ASCO guidelines for the use of sentinel lymph node biopsy (SLNB) in the treatment of breast cancer? [/INST] A 2016 update on SLNB for patients with operable early-stage breast cancer by ASCO advises that SLNB may be offered to the following patients:
Women with multicentric tumors
Women with DCI... |
What are the ASCO guidelines for the use of axillary lymph node dissection (ALND) in the treatment of breast cancer? | A 2016 update on SLNB for patients with operable early-stage breast cancer by ASCO advises that SLNB may be offered to the following patients [188] :
Women with multicentric tumors
Women with DCIS who will be undergoing mastectomy
Women who previously underwent breast and/or axillary surgery
Women who received preoper... | <s>[INST] What are the ASCO guidelines for the use of axillary lymph node dissection (ALND) in the treatment of breast cancer? [/INST] A 2016 update on SLNB for patients with operable early-stage breast cancer by ASCO advises that SLNB may be offered to the following patients [188] :
Women with multicentric tumors
Wom... |
What are the NCCN guidelines on the use of sentinel lymph node biopsy (SLNB) for the treatment of breast cancer? | The NCCN guidelines recommend that SLNB should be performed and is the preferred method of axillary lymph node staging if the patient is an appropriate candidate for SLNB. [72] Candidates include patients who are clinically node negative at the time of breast cancer diagnosis, with or without 1–2 suspicious nodes on im... | <s>[INST] What are the NCCN guidelines on the use of sentinel lymph node biopsy (SLNB) for the treatment of breast cancer? [/INST] The NCCN guidelines recommend that SLNB should be performed and is the preferred method of axillary lymph node staging if the patient is an appropriate candidate for SLNB. [72] Candidates i... |
What are the NCCN guidelines for fine needle aspiration (FNA) and core biopsy in the treatment of breast cancer? | The NCCN recommends fine needle aspiration (FNA) or core biopsy for patients with any of the following characteristics:
Clinically node positive (3 or more positive nodes on physical exam and/or imaging) at time of diagnosis or
≥T2 or ≥N1 and with preoperative systemic therapy planned or
T2–4,N1–3,M0
If FNA or core ... | <s>[INST] What are the NCCN guidelines for fine needle aspiration (FNA) and core biopsy in the treatment of breast cancer? [/INST] The NCCN recommends fine needle aspiration (FNA) or core biopsy for patients with any of the following characteristics:
Clinically node positive (3 or more positive nodes on physical exam ... |
What are the NCCN guidelines for use of sentinel lymph node biopsy (SLNB) in the treatment of breast cancer during pregnancy? | In contrast with ASCO, the NCCN concluded that insufficient data exist on which to base recommendations regarding the use of SLNB in pregnant women. The NCCN advises that whether to use SLNB in pregnancy should be an individualized decision, but cites a review recommending that SLNB should not be offered to pregnant wo... | <s>[INST] What are the NCCN guidelines for use of sentinel lymph node biopsy (SLNB) in the treatment of breast cancer during pregnancy? [/INST] In contrast with ASCO, the NCCN concluded that insufficient data exist on which to base recommendations regarding the use of SLNB in pregnant women. The NCCN advises that wheth... |
What were the ASCO/CAP guidelines for hormone receptor testing in patients with breast cancer? | ER testing of invasive breast cancers by validated immunohistochemistry remains the standard for predicting which patients may benefit from endocrine therapy; no other assays are recommended for this purpose.
Breast cancer samples with 1% to 100% of tumor nuclei positive should be interpreted as ER positive. However, d... | <s>[INST] What were the ASCO/CAP guidelines for hormone receptor testing in patients with breast cancer? [/INST] ER testing of invasive breast cancers by validated immunohistochemistry remains the standard for predicting which patients may benefit from endocrine therapy; no other assays are recommended for this purpose... |
What are the guidelines for breast-conserving surgery with whole-breast radiation therapy (WBRT) in ductal carcinoma in situ (DCIS) breast cancer? | A positive margin is associated with a significant increase in ipsilateral breast tumor recurrence (IBTR); this increased risk is not nullified by the use of WBRT
Negative margins halve the risk of IBTR and a 2 mm margin minimizes the risk of IBTR compared with smaller negative margins.
More widely clear margins do no... | <s>[INST] What are the guidelines for breast-conserving surgery with whole-breast radiation therapy (WBRT) in ductal carcinoma in situ (DCIS) breast cancer? [/INST] A positive margin is associated with a significant increase in ipsilateral breast tumor recurrence (IBTR); this increased risk is not nullified by the use ... |
What are the guidelines for breast-conserving surgery with whole-breast radiation therapy (WBRT) in stages I and II invasive breast cancer? | The following consensus guideline, released in 2014 by the Society of Surgical Oncology and the American Society for Radiation Oncology, addresses margins for breast-conserving surgery with whole-breast irradiation (WBI) in stages I and II invasive breast cancer:
Positive margins are associated with at least a two-fol... | <s>[INST] What are the guidelines for breast-conserving surgery with whole-breast radiation therapy (WBRT) in stages I and II invasive breast cancer? [/INST] The following consensus guideline, released in 2014 by the Society of Surgical Oncology and the American Society for Radiation Oncology, addresses margins for bre... |
What are the ASCO guidelines for postmastectomy radiation therapy in the treatment of breast cancer? | Clinical practice guidelines developed by the American Society of Clinical Oncology (ASCO), recommend that postmastectomy radiation therapy be performed according to the following criteria :
Positive postmastectomy margins
Primary tumors >5 cm
Involvement of ≥4 lymph nodes
Patients with more than four positive lymph n... | <s>[INST] What are the ASCO guidelines for postmastectomy radiation therapy in the treatment of breast cancer? [/INST] Clinical practice guidelines developed by the American Society of Clinical Oncology (ASCO), recommend that postmastectomy radiation therapy be performed according to the following criteria :
Positive ... |
What are the ASCO treatment guidelines for HER2-positive breast cancer? | HER2-targeted therapy is recommended for patients with HER2-positive advanced breast cancer, except for those with clinical congestive heart failure or significantly compromised left ventricular ejection fraction, who should be evaluated on a case-by-case basis.
The combination of trastuzumab, pertuzumab, and a taxane... | <s>[INST] What are the ASCO treatment guidelines for HER2-positive breast cancer? [/INST] HER2-targeted therapy is recommended for patients with HER2-positive advanced breast cancer, except for those with clinical congestive heart failure or significantly compromised left ventricular ejection fraction, who should be ev... |
What are the ASCO guidelines for the use of hormonal adjuvant therapy in the treatment of premenopausal women with breast cancer? | SCO recommends high-risk women receive adjuvant endocrine therapy with ovarian suppression but lower-risk patients should not.
Women with stage II or stage III breast cancers who would ordinarily be advised to receive adjuvant chemotherapy should receive ovarian suppression in addition to endocrine therapy
Women with... | <s>[INST] What are the ASCO guidelines for the use of hormonal adjuvant therapy in the treatment of premenopausal women with breast cancer? [/INST] SCO recommends high-risk women receive adjuvant endocrine therapy with ovarian suppression but lower-risk patients should not.
Women with stage II or stage III breast canc... |
What are the ASCO guidelines for adjuvant endocrine therapy in the treatment of postmenopausal women with breast cancer? | Women with stage II or stage III breast cancers who would ordinarily be advised to receive adjuvant chemotherapy should receive ovarian suppression in addition to endocrine therapy
Women with stage I or II breast cancers at higher risk of recurrence, who might consider chemotherapy, may also be offered ovarian suppres... | <s>[INST] What are the ASCO guidelines for adjuvant endocrine therapy in the treatment of postmenopausal women with breast cancer? [/INST] Women with stage II or stage III breast cancers who would ordinarily be advised to receive adjuvant chemotherapy should receive ovarian suppression in addition to endocrine therapy
... |
What are guidelines on the treatment of breast cancer in young women? | There is no clear role for routine screening by any imaging technique for early breast cancer detection in healthy, average-risk young women. However, in young women with a cancer predisposition syndrome (germline mutation in a known cancer predisposition gene), significant family history, or prior personal history of ... | <s>[INST] What are guidelines on the treatment of breast cancer in young women? [/INST] There is no clear role for routine screening by any imaging technique for early breast cancer detection in healthy, average-risk young women. However, in young women with a cancer predisposition syndrome (germline mutation in a know... |
Which organizations issued guidelines on follow-up care for breast cancer survivors? | The National Comprehensive Cancer Network (NCCN) and the American Cancer Society/American Society of Clinical Oncology (ACS/ASCO) have issued guidelines on followup care for breast cancer survivors. The guidelines differ principally in the timing of care. See the table in the website below. | <s>[INST] Which organizations issued guidelines on follow-up care for breast cancer survivors? [/INST] The National Comprehensive Cancer Network (NCCN) and the American Cancer Society/American Society of Clinical Oncology (ACS/ASCO) have issued guidelines on followup care for breast cancer survivors. The guidelines dif... |
What are ASCO guidelines for use of biomarkers in the treatment of breast cancer? | A guideline from the American Society of Clinical Oncology (ASCO) advises that the only biomarkers that can guide choices of specific treatment regimens in breast cancer are as follows:
Estrogen receptor (ER)
Progesterone receptor (PR)
Human epidermal growth factor receptor 2 (HER2) | <s>[INST] What are ASCO guidelines for use of biomarkers in the treatment of breast cancer? [/INST] A guideline from the American Society of Clinical Oncology (ASCO) advises that the only biomarkers that can guide choices of specific treatment regimens in breast cancer are as follows:
Estrogen receptor (ER)
Progestero... |
What are the NCCN guidelines for radical mastectomy in the treatment of breast cancer? | According to National Comprehensive Cancer Network (NCCN) guidelines, mastectomy with level I/II axillary lymph node dissection is the recommended procedure in patients who respond to neoadjuvant chemotherapy. Other NCCN indications include:
Prior radiation therapy to the breast or chest wall
Radiation therapy contrai... | <s>[INST] What are the NCCN guidelines for radical mastectomy in the treatment of breast cancer? [/INST] According to National Comprehensive Cancer Network (NCCN) guidelines, mastectomy with level I/II axillary lymph node dissection is the recommended procedure in patients who respond to neoadjuvant chemotherapy. Other... |
What is the role of adjuvant therapies in the treatment of breast cancer? | Adjuvant treatment for breast cancer involves radiation therapy and a variety of chemotherapeutic and biologic agents. It is designed to treat micrometastatic disease (or breast cancer cells that have escaped the breast and regional lymph nodes but which have not yet had an established identifiable metastasis). Treatme... | <s>[INST] What is the role of adjuvant therapies in the treatment of breast cancer? [/INST] Adjuvant treatment for breast cancer involves radiation therapy and a variety of chemotherapeutic and biologic agents. It is designed to treat micrometastatic disease (or breast cancer cells that have escaped the breast and regi... |
Which medications are used in the adjuvant treatment of breast cancer? | Medication Summary
Adjuvant treatment for breast cancer involves radiation therapy and a variety of chemotherapeutic and biologic agents. It is designed to treat micrometastatic disease (or breast cancer cells that have escaped the breast and regional lymph nodes but which have not yet had an established identifiable m... | <s>[INST] Which medications are used in the adjuvant treatment of breast cancer? [/INST] Medication Summary
Adjuvant treatment for breast cancer involves radiation therapy and a variety of chemotherapeutic and biologic agents. It is designed to treat micrometastatic disease (or breast cancer cells that have escaped the... |
Which medications in the drug class Antineoplastics, Estrogen Receptor Antagonist are used in the treatment of Breast Cancer? | Bevacizumab, a humanized monoclonal antibody that inhibits angiogenesis, had been approved for use in combination therapy for metastatic breast cancer. In November 2011, however, the US Food and Drug Administration (FDA) revoked its approval for this indication, after concluding that bevacizumab had not been shown to b... | <s>[INST] Which medications in the drug class Antineoplastics, Estrogen Receptor Antagonist are used in the treatment of Breast Cancer? [/INST] Bevacizumab, a humanized monoclonal antibody that inhibits angiogenesis, had been approved for use in combination therapy for metastatic breast cancer. In November 2011, howeve... |
Which medications in the drug class Antineoplastics, PARP Inhibitors are used in the treatment of Breast Cancer? | This class of agents is thought to augment cytotoxic therapy without increasing side effects and to kill cancer cells with DNA repair defects as a single agent. The genomic instability of some tumor cells allows poly (ADP-ribose) polymerase (PARP) inhibitors to have selectivity for the tumor cells over normal cells.
O... | <s>[INST] Which medications in the drug class Antineoplastics, PARP Inhibitors are used in the treatment of Breast Cancer? [/INST] This class of agents is thought to augment cytotoxic therapy without increasing side effects and to kill cancer cells with DNA repair defects as a single agent. The genomic instability of s... |
Which medications in the drug class CDK Inhibitors are used in the treatment of Breast Cancer? | Palbociclib and ribociclib are cyclin-dependent kinases (CDK) 4, 6 inhibitors indicated in combination with an aromatase inhibitor as initial endocrine-based therapy for postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cance... | <s>[INST] Which medications in the drug class CDK Inhibitors are used in the treatment of Breast Cancer? [/INST] Palbociclib and ribociclib are cyclin-dependent kinases (CDK) 4, 6 inhibitors indicated in combination with an aromatase inhibitor as initial endocrine-based therapy for postmenopausal women with hormone rec... |
Which medications in the drug class Aromatase Inhibitors are used in the treatment of Breast Cancer? | In patients receiving adjuvant aromatase inhibitor therapy for breast cancer who are at high risk for fracture, the monoclonal antibody denosumab or either of the bisphosphonates zoledronic acid and pamidronate may be added to the treatment regimen to increase bone mass. These agents are given along with calcium and vi... | <s>[INST] Which medications in the drug class Aromatase Inhibitors are used in the treatment of Breast Cancer? [/INST] In patients receiving adjuvant aromatase inhibitor therapy for breast cancer who are at high risk for fracture, the monoclonal antibody denosumab or either of the bisphosphonates zoledronic acid and pa... |
Which medications in the drug class Antineoplastics, Antimicrotubular are used in the treatment of Breast Cancer? | Use of antimicrotubular therapy may be considered in patients who have received at least 2 chemotherapeutic regimens for metastatic disease. See link for full list of medications. | <s>[INST] Which medications in the drug class Antineoplastics, Antimicrotubular are used in the treatment of Breast Cancer? [/INST] Use of antimicrotubular therapy may be considered in patients who have received at least 2 chemotherapeutic regimens for metastatic disease. See link for full list of medications. </s> |
Which medications in the drug class Tyrosine Kinase Inhibitors are used in the treatment of Breast Cancer? | Tyrosine kinase inhibitors play an important role in the modulation of growth factor signaling. They are commonly combined with other forms of chemotherapy or radiation therapy. See link for full list of medications. | <s>[INST] Which medications in the drug class Tyrosine Kinase Inhibitors are used in the treatment of Breast Cancer? [/INST] Tyrosine kinase inhibitors play an important role in the modulation of growth factor signaling. They are commonly combined with other forms of chemotherapy or radiation therapy. See link for full... |
Which medications in the drug class Monoclonal Antibodies are used in the treatment of Breast Cancer? | Monoclonal antibodies have been engineered to react against specific antigens on cancer cells, thereby potentially helping to enhance the patient’s immune response and prevent cancer cell growth. See link for full list of medications. | <s>[INST] Which medications in the drug class Monoclonal Antibodies are used in the treatment of Breast Cancer? [/INST] Monoclonal antibodies have been engineered to react against specific antigens on cancer cells, thereby potentially helping to enhance the patient’s immune response and prevent cancer cell growth. See ... |
Which medications in the drug class Antineoplastics, Vinca Alkaloid are used in the treatment of Breast Cancer? | Antimetabolite therapy can stop cancer cell growth and cell division by interfering with DNA replication of these cells. These drugs are often first-line agents for breast cancer. See link for full list of medications. | <s>[INST] Which medications in the drug class Antineoplastics, Vinca Alkaloid are used in the treatment of Breast Cancer? [/INST] Antimetabolite therapy can stop cancer cell growth and cell division by interfering with DNA replication of these cells. These drugs are often first-line agents for breast cancer. See link f... |
Which medications in the drug class Antineoplastics, Antimetabolite are used in the treatment of Breast Cancer? | Antimetabolite therapy can stop cancer cell growth and cell division by interfering with DNA replication of these cells. These drugs are often first-line agents for breast cancer. See link for full list of medications. | <s>[INST] Which medications in the drug class Antineoplastics, Antimetabolite are used in the treatment of Breast Cancer? [/INST] Antimetabolite therapy can stop cancer cell growth and cell division by interfering with DNA replication of these cells. These drugs are often first-line agents for breast cancer. See link f... |
Which medications in the drug class Calcium Metabolism Modifiers are used in the treatment of Breast Cancer? | Bisphosphonates are complementary to chemotherapy and hormone therapy because they may lessen the damage to bone from metastatic disease. Bisphosphonates inhibit osteoclast function and reduce the resorption of bone. An intravenous bisphosphonate should be used in combination with oral calcium citrate and vitamin D sup... | <s>[INST] Which medications in the drug class Calcium Metabolism Modifiers are used in the treatment of Breast Cancer? [/INST] Bisphosphonates are complementary to chemotherapy and hormone therapy because they may lessen the damage to bone from metastatic disease. Bisphosphonates inhibit osteoclast function and reduce ... |
Which medications in the drug class Antineoplastics, Anthracycline are used in the treatment of Breast Cancer? | Anthracyclines work in multiple ways, including intercalation between DNA base pairs and inhibition of type II topoisomerase function, resulting in inhibition of cell replication and transcription. They also work by inhibition of DNA helicase, resulting in DNA cleavage. See link for full list of medications. | <s>[INST] Which medications in the drug class Antineoplastics, Anthracycline are used in the treatment of Breast Cancer? [/INST] Anthracyclines work in multiple ways, including intercalation between DNA base pairs and inhibition of type II topoisomerase function, resulting in inhibition of cell replication and transcri... |
Which medications in the drug class Antineoplastics, Alkylating are used in the treatment of Breast Cancer? | Alkylating agents constitute one of the earliest classes of antineoplastic agents used to treat cancer. They work by cross-linking DNA, which impedes cellular growth. They can be used alone or in combination with other chemotherapeutic agents. See link for full list of medications. | <s>[INST] Which medications in the drug class Antineoplastics, Alkylating are used in the treatment of Breast Cancer? [/INST] Alkylating agents constitute one of the earliest classes of antineoplastic agents used to treat cancer. They work by cross-linking DNA, which impedes cellular growth. They can be used alone or i... |
Which medications in the drug class PD-1/PD-L1 Inhibitors are used in the treatment of Breast Cancer? | PD-L1 is expressed on the surface of activated T cells under normal conditions; binding PDL1 inhibits immune activation and reduces T-cell cytotoxic activity when bound. This negative feedback loop is essential for maintaining normal immune responses and limits T-cell activity to protect normal cells during chronic inf... | <s>[INST] Which medications in the drug class PD-1/PD-L1 Inhibitors are used in the treatment of Breast Cancer? [/INST] PD-L1 is expressed on the surface of activated T cells under normal conditions; binding PDL1 inhibits immune activation and reduces T-cell cytotoxic activity when bound. This negative feedback loop is... |
Which medications in the drug class PI3K Inhibitors are used in the treatment of Breast Cancer? | PI3K inhibitor indicated in combination with fulvestrant for treatment of men and postmenopausal women with HR+/HER2- PIK3CA-mutated advanced or metastatic breast cancer following progression on or after an endocrine-based regimen. | <s>[INST] Which medications in the drug class PI3K Inhibitors are used in the treatment of Breast Cancer? [/INST] PI3K inhibitor indicated in combination with fulvestrant for treatment of men and postmenopausal women with HR+/HER2- PIK3CA-mutated advanced or metastatic breast cancer following progression on or after an... |
What are the risk factors for breast cancer? | Risk factors for breast cancer include age, family history of breast cancer, certain genetic mutations, hormone replacement therapy, alcohol consumption, obesity, and radiation exposure. | <s>[INST] What are the risk factors for breast cancer? [/INST] Risk factors for breast cancer include age, family history of breast cancer, certain genetic mutations, hormone replacement therapy, alcohol consumption, obesity, and radiation exposure. </s> |
How can I reduce my risk of breast cancer? | To reduce the risk of breast cancer, individuals can maintain a healthy weight, be physically active, limit alcohol intake, avoid smoking, breastfeed if possible, and undergo regular screenings. | <s>[INST] How can I reduce my risk of breast cancer? [/INST] To reduce the risk of breast cancer, individuals can maintain a healthy weight, be physically active, limit alcohol intake, avoid smoking, breastfeed if possible, and undergo regular screenings. </s> |
Is breast cancer hereditary? | While most cases of breast cancer are not hereditary, about 5-10% of breast cancers are linked to inherited genetic mutations, such as BRCA1 and BRCA2. Individuals with a family history of breast cancer may benefit from genetic counseling and testing. | <s>[INST] Is breast cancer hereditary? [/INST] While most cases of breast cancer are not hereditary, about 5-10% of breast cancers are linked to inherited genetic mutations, such as BRCA1 and BRCA2. Individuals with a family history of breast cancer may benefit from genetic counseling and testing. </s> |
What should I do if I find a lump in my breast? | If you find a lump or notice any other changes in your breast, it's essential to promptly consult a healthcare provider for evaluation. They may recommend further tests, such as a mammogram or biopsy, to determine the cause of the lump and develop an appropriate treatment plan. | <s>[INST] What should I do if I find a lump in my breast? [/INST] If you find a lump or notice any other changes in your breast, it's essential to promptly consult a healthcare provider for evaluation. They may recommend further tests, such as a mammogram or biopsy, to determine the cause of the lump and develop an app... |
Can men get breast cancer? | Yes, although much less common than in women, men can develop breast cancer. It is estimated that about 1 in 833 men will be diagnosed with breast cancer in their lifetime. | <s>[INST] Can men get breast cancer? [/INST] Yes, although much less common than in women, men can develop breast cancer. It is estimated that about 1 in 833 men will be diagnosed with breast cancer in their lifetime. </s> |
Is breast cancer preventable? | While it's not always possible to prevent breast cancer, certain lifestyle choices and risk-reducing measures, such as maintaining a healthy weight, being physically active, and avoiding excessive alcohol consumption, can help lower the risk. | <s>[INST] Is breast cancer preventable? [/INST] While it's not always possible to prevent breast cancer, certain lifestyle choices and risk-reducing measures, such as maintaining a healthy weight, being physically active, and avoiding excessive alcohol consumption, can help lower the risk. </s> |
Can breast cancer spread to other parts of the body? | Yes, breast cancer can spread (metastasize) to other parts of the body, such as the bones, liver, lungs, or brain, if not detected and treated early. | <s>[INST] Can breast cancer spread to other parts of the body? [/INST] Yes, breast cancer can spread (metastasize) to other parts of the body, such as the bones, liver, lungs, or brain, if not detected and treated early. </s> |
What are the side effects of breast cancer treatment? | Side effects of breast cancer treatment may vary depending on the type of treatment but can include fatigue, nausea, hair loss, changes in appetite, menopausal symptoms, and emotional distress. | <s>[INST] What are the side effects of breast cancer treatment? [/INST] Side effects of breast cancer treatment may vary depending on the type of treatment but can include fatigue, nausea, hair loss, changes in appetite, menopausal symptoms, and emotional distress. </s> |
What support services are available for breast cancer patients? | Breast cancer patients have access to various support services, including counseling, support groups, financial assistance programs, and resources for managing treatment-related side effects and coping with the emotional impact of the disease. | <s>[INST] What support services are available for breast cancer patients? [/INST] Breast cancer patients have access to various support services, including counseling, support groups, financial assistance programs, and resources for managing treatment-related side effects and coping with the emotional impact of the dis... |
Can breast cancer come back after treatment? | Yes, breast cancer can recur even after successful treatment. Regular follow-up appointments and monitoring are essential to detect any signs of recurrence early and adjust treatment as needed. | <s>[INST] Can breast cancer come back after treatment? [/INST] Yes, breast cancer can recur even after successful treatment. Regular follow-up appointments and monitoring are essential to detect any signs of recurrence early and adjust treatment as needed. </s> |
How can I support a loved one diagnosed with breast cancer? | Supporting a loved one with breast cancer involves offering emotional support, assisting with practical needs, accompanying them to medical appointments, and educating oneself about the disease and available resources. | <s>[INST] How can I support a loved one diagnosed with breast cancer? [/INST] Supporting a loved one with breast cancer involves offering emotional support, assisting with practical needs, accompanying them to medical appointments, and educating oneself about the disease and available resources. </s> |
What are the main types of medications used to treat breast cancer? | The main types of medications used to treat breast cancer include chemotherapy drugs, hormone therapy medications, targeted therapy drugs, and immunotherapy agents. | <s>[INST] What are the main types of medications used to treat breast cancer? [/INST] The main types of medications used to treat breast cancer include chemotherapy drugs, hormone therapy medications, targeted therapy drugs, and immunotherapy agents. </s> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.